19-3885804-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_033064.5(ATCAY):c.37G>C(p.Val13Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000322 in 1,552,228 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033064.5 missense
Scores
Clinical Significance
Conservation
Publications
- cerebellar ataxiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Cayman type cerebellar ataxiaInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATCAY | NM_033064.5 | c.37G>C | p.Val13Leu | missense_variant | Exon 2 of 13 | ENST00000450849.7 | NP_149053.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.00000635 AC: 1AN: 157552 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000286 AC: 4AN: 1400064Hom.: 0 Cov.: 31 AF XY: 0.00000290 AC XY: 2AN XY: 690622 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74324 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.37G>C (p.V13L) alteration is located in exon 2 (coding exon 1) of the ATCAY gene. This alteration results from a G to C substitution at nucleotide position 37, causing the valine (V) at amino acid position 13 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at